Clinical Trial

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

Recruiting
View on ClinicalTrials.gov →
Summary
Background: \- Innate immunity is the process by which white blood cells and other parts of the immune system sense and respond to potential infections by causing an inflammation. Researchers are interested in studying how the body responds to certain environmental factors, and whether the body s response can contribute to chronic illnesses or diseases such as asthma and certain types of cancers. Objectives: \- To examine how specific genes and proteins in blood cells respond to environmental exposures. Eligibility: \- Healthy volunteers between 18 and 45 years of age. Design: * The study will involve one visit of 45 to 60 minutes. * Participants will be screened with a brief physical examination and finger stick to determine if they are eligible to donate blood for the study, and will complete a questionnaire about any medications or other drugs (e.g., cigarettes) they may be taking. * Participants will provide a blood sample for research purposes.
Protocol Amendment History 300 amendments
This ClinicalTrials.gov record has been amended 300 times since 2010-06-11; most recent amendment 2026-07-15.
Status change: Enrolling by Invitation → Recruiting 2021-10-13
Status change: Recruiting → Enrolling by Invitation 2014-12-23
Status change: Not Yet Recruiting → Recruiting 2012-02-29
Status change: Recruiting → Not Yet Recruiting 2011-03-23
Trial Details
NCT Number NCT01143480
Lead Sponsor National Institute of Environmental Health Sciences (NIEHS)
Conditions Asthma, Atherosclerosis, Metabolic Syndrome, Insulin Resistance, Cancer
Enrollment 725 participants
Start Date 2012-07-30
Updated on ClinicalTrials.gov 2026-08-07